Longitudinal measurement of anticardiolipin antibodies during normal pregnancy: a prospective study.

Abstract:

:We have previously shown that elevation of anticardiolipin antibodies (aCL) at the first prenatal visit is associated with increased fetal loss in normal pregnancy. The variation in aCL levels during normal pregnancy has not been established. To examine this question we measured IgG, IgM and IgA aCL levels five times during pregnancy at weeks 5-15, 16-25, 26-35, 36-37 and at delivery. Data were analyzed to determine: (a) the within and between subject variability of aCL during pregnancy; (2) the temporal trend of aCL; and (3) the relation of serial measures of aCL with maternal complications of pregnancy. We divided our cohort of 354 subjects into two groups. Group A included those subjects with consistently normal levels of aCL and group B those subjects with at least one elevated level of aCL. In group A the within subject variability was relatively low (28-34%). In group B we found wide fluctuations in aCL levels and a within subject variability of 88-91%. Subjects in group B had no increase in maternal complications of pregnancy. The present data suggest that aCL may fluctuate significantly during normal pregnancy and there is little clinical value in measuring aCL on a serial basis during pregnancy.

journal_name

Lupus

journal_title

Lupus

authors

Lynch AM,Rutledge JH,Stephens JK,Murphy JR,Marlar RA,Davila GH,Santos ME,Emlen W

doi

10.1177/096120339500400506

subject

Has Abstract

pub_date

1995-10-01 00:00:00

pages

365-9

issue

5

eissn

0961-2033

issn

1477-0962

journal_volume

4

pub_type

杂志文章

相关文献

LUPUS文献大全
  • Facial telangiectasia: an unusual manifestation of neonatal lupus erythematosus.

    abstract::Neonatal lupus erythematosus (NLE) is an uncommon condition usually associated with maternal anti-Ro autoantibodies. The cutaneous lesions of NLE are usually transient, disappearing about six months after birth, but telangiectasia is a rare complication of NLE which persists. Telangiectasias are small focal red macule...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203311430701

    authors: Guinovart RM,Vicente A,Rovira C,Suñol M,González-Enseñat MA

    更新日期:2012-04-01 00:00:00

  • SLEDAI-2K for a 30-day window.

    abstract::The aim of our study was to determine whether the SLEDAI-2K calculated using a timeframe of 30 days prior to a visit for clinical and laboratory variables was equivalent to the prescribed 10-day period. One hundred forty nine consecutive lupus patients seen over 9 weeks at the University of Toronto Lupus Clinic enroll...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309346505

    authors: Touma Z,Urowitz MB,Gladman DD

    更新日期:2010-01-01 00:00:00

  • Infliximab-induced discoid lupus erythematosus.

    abstract::Anti-tumor necrosis factor-alpha (TNF-α) immunotherapy is currently used in the treatment of various inflammatory diseases such as rheumatoid arthritis, psoriasis, psoriatic arthritis, ankylosing spondylitis and Crohn's disease. Infliximab is a chimeric monoclonal antibody that binds to transmembrane-bound and soluble...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313479423

    authors: Cemil BC,Atas H,Canpolat F,Akca Y,Sasmaz R

    更新日期:2013-04-01 00:00:00

  • Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States.

    abstract::We examined the prevalence of clinical and immunologic features of systemic lupus erythematosus (SLE) by race, sex and age in a population-based study of 265 SLE patients. Patients fulfilled the American College of Rheumatology classification criteria. The median time between diagnosis and study enrollment was 13 mont...

    journal_title:Lupus

    pub_type: 杂志文章,多中心研究

    doi:10.1191/0961203302lu161oa

    authors: Cooper GS,Parks CG,Treadwell EL,St Clair EW,Gilkeson GS,Cohen PL,Roubey RA,Dooley MA

    更新日期:2002-01-01 00:00:00

  • The lupus impact tracker is responsive to changes in clinical activity measured by the systemic lupus erythematosus responder index.

    abstract::Objective The lupus impact tracker (LIT) is a 10-item patient reported outcome tool to measure the impact of systemic lupus erythematosus or its treatment on patients' daily lives. Herein, we describe the responsiveness of the LIT and LupusQoL to changes in disease activity, using the systemic lupus erythematosus resp...

    journal_title:Lupus

    pub_type: 杂志文章,多中心研究

    doi:10.1177/0961203316667494

    authors: Devilliers H,Bonithon-Kopp C,Jolly M

    更新日期:2017-04-01 00:00:00

  • Photoprotective habits in children with systemic lupus erythematosus.

    abstract:BACKGROUND:Systemic lupus erythematosus (SLE) is a complex autoimmune disease that can involve multiple organ systems. Exposure to ultraviolet radiation (UVR) can exacerbate pre-existing SLE, and can even induce systemic manifestations. This study aimed to investigate the photoprotective habits of children with SLE and...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320930098

    authors: Janthongsri T,Wisuthsarewong W,Nitiyarom R

    更新日期:2020-07-01 00:00:00

  • Skeletal muscle lymphocytic vasculitis in systemic lupus erythematosus: relation to disease activity.

    abstract::Lymphocytic vasculitis (LV) characterises systemic lupus erythematosus (SLE) and this potentially reversible lesion, which may be subclinical, may imply overt systemic disease activity. Needle quadriceps muscle biopsy was performed in 26 unselected patients with SLE and the presence of LV in these muscle specimens was...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339500400213

    authors: Lim KL,Lowe J,Powell RJ

    更新日期:1995-04-01 00:00:00

  • Maternal deaths in women with lupus nephritis: a review of published evidence.

    abstract:BACKGROUND AND OBJECTIVES:Pregnancies in women with systemic lupus erythematosus (SLE) and lupus nephritis are considered high-risk due to high rates of maternal and fetal complications. However, there has not been a formal analysis addressing the issue of maternal deaths in these women. The aim of this study was to pe...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203311434939

    authors: Ritchie J,Smyth A,Tower C,Helbert M,Venning M,Garovic V

    更新日期:2012-04-01 00:00:00

  • Cyclophosphamide in combination with glucocorticoids for severe neuropsychiatric systemic lupus erythematosus: a retrospective, observational two-centre study.

    abstract::Cyclophosphamide (CYC) is used in severe neuropsychiatric systemic lupus erythematosus (NPSLE), but long-term data regarding its efficacy and safety are lacking. We identified NPSLE cases who received CYC from two centres during the period 1999-2013 and had regular follow-up. General and neuropsychiatric outcome at la...

    journal_title:Lupus

    pub_type: 杂志文章,多中心研究

    doi:10.1177/0961203315622821

    authors: Fanouriakis A,Pamfil C,Sidiropoulos P,Damian L,Flestea A,Gusetu G,Rednic S,Bertsias G,Boumpas DT

    更新日期:2016-05-01 00:00:00

  • Long-term systemic lupus erythematosus disease control after allogeneic bone marrow transplantation.

    abstract::Systemic lupus erythematosus (SLE), a disorder of the immune system, is potentially curable by allogeneic bone marrow transplantation (alloBMT). Until recently, alloBMT was limited by donor availability and toxicity. Reduced intensity conditioning (RIC) combined with post-transplantation cyclophosphamide (PTCy) has im...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316669242

    authors: Gladstone DE,Petri M,Bolaños-Meade J,Dezern AE,Jones RJ,Fine D,Brodsky RA

    更新日期:2017-06-01 00:00:00

  • The functional p53 codon 72 polymorphism is associated with systemic lupus erythematosus.

    abstract::The aim of the study is to investigate whether the functional p53 codon 72 polymorphism is associated with susceptibility to SLE and its clinical features. A polymerase chain reaction of genomic DNA-restriction fragment length polymorphism was used to determine genotypes of the p53 codon 72 in 90 SLE patients and 114 ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203305lu2224oa

    authors: Lee YH,Rho YH,Choi SJ,Ji JD,Song GG

    更新日期:2005-01-01 00:00:00

  • The dual role of innate immunity in antiphospholipid syndrome and systemic lupus erythematosus.

    abstract::Antiphospholipid syndrome (APS), as a primary disease or a secondary syndrome in systemic lupus erythematosus (SLE), is characterized by the presence of antiphospholipid antibodies (aPL) and a clinical event. It is likely that both genetic and environmental factors lead to the development of aPL and progression to dis...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314548248

    authors: Salem D,Subang R,Laplante P,Levine JS,Rauch J

    更新日期:2014-10-01 00:00:00

  • Ro52, Ro60 and La IgG autoantibody levels and Ro52 IgG subclass profiles longitudinally throughout pregnancy in congenital heart block risk pregnancies.

    abstract::Congenital heart block occurs in fetuses of Ro/SSA and La/SSB positive women. To investigate the stability of maternal autoantibody levels during pregnancy, we followed Ro52, Ro60 and La autoantibody IgG level variation and Ro52 subclass profiles longitudinally in selected congenital heart block risk pregnancies. Seru...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203306lu2309oa

    authors: Strandberg L,Salomonsson S,Bremme K,Sonesson S,Wahren-Herlenius M

    更新日期:2006-01-01 00:00:00

  • Time trend and risk factors of avascular bone necrosis in patients with systemic lupus erythematosus.

    abstract::Objectives The objective of this paper is to study the time trend and risk factors of avascular bone necrosis (AVN) in patients with systemic lupus erythematosus (SLE). Methods Between 1999 and 2014, patients who fulfilled the ACR criteria for SLE and developed symptomatic AVN were identified from our cohort database ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316676384

    authors: Tse SM,Mok CC

    更新日期:2017-06-01 00:00:00

  • Autoimmune pancreatitis as the initial presentation of systemic lupus erythematosus.

    abstract::Pancreatitis is a relatively rare complication in systemic lupus erythematosus (SLE). Here we present a case of SLE associated with autoimmune pancreatitis. A 37-year old woman was admitted to our hospital because of fever, skin rash, proteinuria and abdominal pain. A diagnosis of SLE was made based on her clinical, l...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203306073137

    authors: Kobayashi S,Yoshida M,Kitahara T,Abe Y,Tsuchida A,Nojima Y

    更新日期:2007-01-01 00:00:00

  • C6 knock-out mice are protected from thrombophilia mediated by antiphospholipid antibodies.

    abstract:BACKGROUND:Complement activation plays a role in pathogenesis of the antiphospholipid syndrome (APS), but the involvement of the C5b-9 membrane attack complex (MAC) is unknown. Here we studied the effects of human polyclonal antiphospholipid (aPL) antibodies on thrombosis and tissue factor (TF) up-regulation in C6 defi...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203312458839

    authors: Carrera-Marín A,Romay-Penabad Z,Papalardo E,Reyes-Maldonado E,García-Latorre E,Vargas G,Shilagard T,Pierangeli S

    更新日期:2012-12-01 00:00:00

  • Prolactin levels in patients with systemic lupus erythematosus: a case controlled study.

    abstract::Recent accumulated evidence suggests that prolactin (PRL) is an important immunomodulator and might have a role in the pathogenesis of systemic lupus erythematosus (SLE). Our aim was to assess the frequency of hyperprolactinemia in women with SLE and to evaluate its correlation with disease activity. PRL plasma levels...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120398678920361

    authors: Jimena P,Aguirre MA,López-Curbelo A,de Andrés M,Garcia-Courtay C,Cuadrado MJ

    更新日期:1998-01-01 00:00:00

  • False-positive IgM for CMV in pregnant women with autoimmune disease: a novel prognostic factor for poor pregnancy outcome.

    abstract::Our aims were to assess the frequency of false-positive IgM antibodies for cytomegalovirus in pregnant women with autoimmune diseases and in healthy women (controls) and to determine their relationship with pregnancy outcome. Data from 133 pregnancies in 118 patients with autoimmune diseases and from 222 pregnancies i...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203310361350

    authors: De Carolis S,Santucci S,Botta A,Garofalo S,Martino C,Perrelli A,Salvi S,Degennaro V,de Belvis A,Ferrazzani S,Scambia G

    更新日期:2010-06-01 00:00:00

  • Mechanisms involved in the p62-73 idiopeptide-modulated delay of lupus nephritis in SNF(1) mice.

    abstract::The F(1) progeny of the (SWR × NZB) cross develop a lupus-like disease with high serum titers of autoantibodies, and increased frequency and severity of immune complex-mediated glomerulonephritis in females. In previous work, we found that an idiotypic peptide corresponding to aa62-73 (p62-73) of the heavy chain varia...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203312461964

    authors: Nyland JF,Stoll ML,Jiang F,Feng F,Gavalchin J

    更新日期:2012-12-01 00:00:00

  • Progressive multifocal leukoencephalopathy - the importance of early diagnosis illustrated in four cases.

    abstract::Progressive multifocal leukoencephalopathy (PML) is a rare, deadly demyelinating disease of the central nervous system, which is caused by a reactivation of the DNA polyomavirus JC and occurs in immunosuppressed individuals. So far, only 25 cases have been described in patients with SLE and none survived without antiv...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308089445

    authors: Nived O,Bengtsson AA,Jönsen A,Sturfelt G

    更新日期:2008-11-01 00:00:00

  • Relationship of anticardiolipin antibodies and antiphospholipid syndrome to HLA-DR7 in Mexican patients with systemic lupus erythematosus (SLE).

    abstract::We studied IgG and IgM anticardiolipin antibodies (aCL) by an ELISA method in 80 Mexican systemic lupus erythematosus (SLE) patients and 378 of their first degree relatives. Sixty five percent of SLE patients and 16% of their relatives were positive for aCL. We also determined allele and haplotype frequencies of Major...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339700600108

    authors: Granados J,Vargas-Alarcón G,Drenkard C,Andrade F,Melín-Aldana H,Alcocer-Varela J,Alarcón-Segovia D

    更新日期:1997-01-01 00:00:00

  • Anti-glycan antibodies as biomarkers for diagnosis and prognosis.

    abstract::Glycans (sugars or carbohydrates) are predominant surface components of cells such as erythrocytes, immune cells and microorganisms. As such, they give rise to high levels of anti-glycan antibodies of all classes. Antibodies to certain defined mono, di and oligosaccharides that are common in bacterial, fungal and para...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203306lu2331oa

    authors: Dotan N,Altstock RT,Schwarz M,Dukler A

    更新日期:2006-01-01 00:00:00

  • Contribution of polymorphism in codon 72 of p53 gene to systemic lupus erythematosus in Poland.

    abstract::The contribution of the p53 Arg72Pro polymorphism in the development of systemic lupus erythematosus (SLE) remains controversial. We investigated the frequency of the p53 Arg72Pro genotype in patients with SLE (n = 155) and in controls (n = 150) in Poland. We found a weak contribution of the Arg/Arg genotype to the mo...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203307084722

    authors: Piotrowski P,Lianeri M,Mostowska M,Wudarski M,Chwalinska-Sadowska H,Jagodzinski PP

    更新日期:2008-02-01 00:00:00

  • Lymphocyte subsets in a large cohort of patients with systemic lupus erythematosus.

    abstract::In search of markers of disease activity in patients with SLE we have investigated blood lymphocyte subsets from a large cohort of patient. Seventy-one patients were studied using a well-defined panel of fluorescent monoclonal antibodies which recognize the major T, B and NK lymphocyte subsets and activated cells. Flo...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339300200404

    authors: Erkeller-Yüsel F,Hulstaart F,Hannet I,Isenberg D,Lydyard P

    更新日期:1993-08-01 00:00:00

  • Deciphering systemic lupus erythematosus-associated serum biomarkers reflecting apoptosis and disease activity.

    abstract::Systemic lupus erythematosus (SLE) is a severe chronic inflammatory autoimmune connective tissue disease. Despite major efforts, SLE remains a poorly understood disease with unpredictable course, unknown etiology and complex pathogenesis. Apoptosis combined with deficiency in clearing apoptotic cells is an important e...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316669240

    authors: Delfani P,Sturfelt G,Gullstrand B,Carlsson A,Kassandra M,Borrebaeck CA,Bengtsson AA,Wingren C

    更新日期:2017-04-01 00:00:00

  • In vivo models of thrombosis for the antiphospholipid syndrome.

    abstract::Utilizing this unique animal model of thrombosis we demonstrated that human (IgG, IgM or IgA) polyclonal and monoclonal antiphospholipid antibodies derived from APS patients have a significant enhancing effect on thrombus formation. This effect is reversed by treatment of the mice with hydroxychloroquine (plaquenil). ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/096120339600500524

    authors: Pierangeli SS,Harris EN

    更新日期:1996-10-01 00:00:00

  • Autoimmune thyroid disorders in SLE in Singapore.

    abstract::One hundred and twenty-nine patients with systemic lupus erythematosus were screened for thyroid function tests. Of these, 8.9% had hyperthyroidism and 3.9% Hashimoto's thyroiditis. Euthyroid sick syndrome was present in 47.8% of patients. There was a high prevalence of antimicrosomal and antithyroglobulin antibodies ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339300200109

    authors: Boey ML,Fong PH,Lee JS,Ng WY,Thai AC

    更新日期:1993-02-01 00:00:00

  • Development of systemic lupus erythematosus in a rheumatoid arthritis patient with anti-ribosomal P protein antibody.

    abstract::We describe a patient with rheumatoid arthritis (RA) whose sera contained a high titre of an antibody targeting cytoplasmic ribosomal P proteins (anti-P). This association preceded by 6 years the development of serological and clinical manifestations of systemic lupus erythematosus (SLE). The clinical significance of ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339700600910

    authors: Hamasaki K,Mimura T,Kanda H,Morino N,Yazaki Y,Nojima Y

    更新日期:1997-01-01 00:00:00

  • Naturally occurring anti-idiotypic antibodies reactive with anti-DNA antibodies in systemic lupus erythematosus.

    abstract::The levels of 'putative' anti-idiotypic antibodies reactive with F(ab')2 fragments of affinity purified DNA binding antibodies from five SLE patients were measured in the serum of active and inactive systemic lupus erythematosus (SLE) patients, their relatives, spouses and healthy non-related individuals. Serum anti-i...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120398678919958

    authors: Williams WM,Isenberg DA

    更新日期:1998-01-01 00:00:00

  • Impact of markers of endothelial injury and hypercoagulability on systemic lupus erythematosus.

    abstract::We have explored the relationship between possible hemostatic changes and clinical manifestation of the systemic lupus erythematosus (SLE) as a function of greater or lesser disease activity according to Systemic Lupus Erythematosus Disease Activity Index-2000 (SLEDAI-2K) criteria. Endothelial injury and hypercoagulab...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319899478

    authors: Cicarini WB,Duarte RCF,Ferreira KS,Loures CMG,Consoli RV,Neiva CLS,de Pádua PM,Nunes FFC,Alves LCV,Reis EA,Moreira CC,Guimarães TMPD,de Toledo VPCP,Carvalho MDG

    更新日期:2020-02-01 00:00:00